Perspectives on infection challenges and solutions

Disinfection and Decontamination: Principles, Applications and Related Issues

Volumn , Issue , 2007, Pages 1-22

  Manivannan, Gurusamy ^a  

^a Milk Quality and Animal Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951258860     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (78)

1. Armelagos, G.J., The viral superhighway, The Sciences, 24, 1998.
2. www.cdc.gov.
3. The agricultural use of antibiotics and its implications for human health, United States General Accounting Office, RCED-99-4 (April), 1999.
4. Black, R.E., Morris, S.S., and Bryce, J., Where and why are 10 million children dying every year? Lancet, 361 (June), 2226, 2003.
5. Drug resistance threatens to reverse medical progress, World Health Organization, 2000.
6. Schraag, J., Avian influenza: Why infection prevention and control maybe our only effective weapon, Infection Control Today, November, 32, 2006.
7. Avian influenza (“bird flu”)-Fact sheet, World Health Organization, 2006.
8. Key facts about avian influenza (bird flu) and avian influenza A (H5N1) virus, Centers for Disease Control and Prevention, 2006.
9. Zelicoff, A.P. and Bellomo, M., Microbe: Are we ready for the next plague? AMACOM/American Management Association, 2006.
10. Dawkins, R. and Krebs, J.R., Arms races between and within species, Proc. R. Soc. London, B205, 489, 1979.
11. Older Americans 2000: Key indicators of well being, www.agingstats.gov/chartbook2000, Federal Interagency Forum on Aging Related Statistics, 2000.
12. The future of human life expectancy: Have we reached the ceiling or is the sky the limit? National Institute on Aging-Research Highlights in the Demography and Economics of Aging, March (8), 1, 2006.
13. Greene, L., Emerging infectious diseases, Infection Control Today, 10 (9), 46, 2006.
14. Lederberg, J., Shope, R.E., and Oaks, S.C.J., Emerging Infections: Microbial Threats to Health in the United States, Institute of Medicine, National Academy Press, Washington, DC, 1992.
15. A public health action plan to combat antimicrobial resistance Part I: Domestic issues, 2005 Annual Report, www.cdc.gov, 2006.
16. Hughes, J.M. and Tenover, F.C., Infectious disease challenges of the 1990s, Infect. Med., 13 (9), 788, 1996.
17. Berkelman, R.L., Bryan, R.T., Osterholm, M.T., Le Duc, J.W., and Hughes, J.M., Infectious disease surveillance:Acrumbling foundation, Science, 264 (5157), 368, 1994.
18. MacKenzie, W.R., Hoxie, N.J., Proctor, M.E., Gradus, M.S., Blair, K.A., Peterson, D.E., et al., A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply, N. Engl. J. Med., 331 (3), 161, 1994.
19. Assessment of inadequately filtered public drinking water-Washington, DC, December 1993, Morb. Mortal. Wkly. Rep., 43 (36), 661, 1994.
20. Food safety from farm to table: A new strategy for the 21st century, U.S. Food and Drug Administration, Discussion draft, Washington DC, 1997.
21. Foodborne pathogens: Risks and consequences, Council for Agricultural Science and Technology, Task Force Report, 122, 1994.
22. Altekruse, S.K., Cohen, M.L., and Swerdlow, D.L, Emerging foodborne diseases, Emerg. Infect. Dis., 3 (3), 285, 1997.
23. Manchester, A. and Clauson, A., 1994 Spending for food away from home outpaces food at home, Food rev., 18, 12, 1995.
24. Zink, D.L., The impact of consumer demands and trends on food processing, Emerg. Infect. Dis., 3 (4), 467, 1997.
25. Paci, E., Exploring new tourism marketing opportunities around the world, Proceedings of the 11th General Assembly of the World Tourism Organization, Cairo, Egypt, 1995.
26. Calvin, L., Response to US foodborne illness outbreaks associated with imported produce, USDA Bulletin number 789-5, 2004.
27. CDC, Antimicrobial resistance in healthcare settings, http://www.cdc.gov/ncidod/dhqp/ar.html#2 (accessed on December 11, 2006).
28. Levy, S.B., The Antibiotic Paradox: How Miracle Drugs Are Destroying the Miracle, Plenum Press, New York, 1992.
29. Chapman, J.S., Diehl, M.A., and Fearnside, K.B., Preservative tolerance and resistance, Int. J. Cosmet. Sci., 20, 31, 1998.
30. Tenover, F.C., Mechanisms of antimicrobial resistance in bacteria, Am. J. Infect. Control, 34, S3, 2006.
31. Rice, L.B., Antimicrobial resistance in gram-positive bacteria, Am. J. Infect. Control, 34, S11, 2006.
32. Martinez, J.E., Resistance to disinfectants, Part 1, Bioprocess Int. (September), 32, 2005.
33. Fidler, D.P., Return of the fourth horseman: Emerging infectious diseases and international law, Minn. Law Rev., 81 (3), 771, 1997.
34. Fidler, D.P., The globalization of public health: Emerging infectious diseases and international relations, Ind. J. Global Leg. Stud., 5 (1), 11, 1997.
35. Fidler, D.P., Legal issues associated with antimicrobial drug resistance, Emerg. Infect. Dis., 4 (2), 169, 1998.
36. DeLoach, C. and Brown, J., Cleaning for health: Understanding green cleaning, ASHES Conference, Phoenix, AZ, September, 25, 2005.
37. Weinstein, R.A., Nosocomial infection update, Emerg. Infect. Dis., 4 (3), 416, 1998.
38. Dettenkofer, M., Wenzler, S., Amthor, S., Anter, G., Motschzall, E., and Daschner, F.D., Does disinfection of environmental surfaces influence nosocomial infection rates? A systematic review, Am. J. Infect. Control, 32 (2), 84, 2004.
39. Dettenkofer, M. and Block, C., Hospital disinfection: Efficacy and safety issues, Curr. Opin. Infect. Dis., 18 (4), 320, 2005.
40. Weinstein, R.A., SHEA consensus panel report: A smooth takeoff, Infect. Control Hosp. Epidemiol., 19, 91, 1998.
41. Villegas, M.V. and Hartstein, A.I., Acinetobacter outbreaks, 1977-2000, Infect. Control Hosp. Epidemiol., 24, 284, 2003.
42. Hanberger, H., Garcia-Rodriguez, J.A., Gobernado, M., Goossens, H., Nilsson, L.E., and Struelens, M.J., Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portugese ICU study groups, JAMA, 281, 67, 1999.
43. Seifert, H., Boullion, B., Schulze, A., and Pulverer, G., Plasmid DNA profiles of Acinetobacter baumannii: Clinical application in a complex endemic setting, Infect. Control Hosp. Epidemiol., 15, 520, 1994.
44. Devaud, M., Kayser, F.H., and Bachi, B., Transposon-mediated multiple antibiotic resistance in Acinetobacter strains, Antimicrob. Agents Chemother., 22, 323, 1982.
45. Segal, H., Thomas, R., and Gay, E.B., Characterization of class 1 integron resistance gene cassettes and the identification of a novel IS-like element in Acinetobacter baumannii, Plasmid, 49, 169, 2003.
46. Poirel, L., Menuteau, O., Agoli, N., Cattoen, C., and Nordmann, P., Outbreak of extended spectrum beta-lactamase VEB-1 producing isolates of Acinetobacter baumannii in a french hospital, J. Clin. Microbiol., 41, 3542, 2003.
47. Fournier, P.E., Vallenet, D., Barbe, V., Audic, S., Ogata, H., Poirel, L., et al., Comparative genomics of multidrug resistance in Acinetobacter baumannii, PLoS Genet., 2:e7, 2006.
48. Richet, H. and Fournier, P.E., Nosocomial infections caused by Acinetobacter baumannii: A major threat worldwide, Infect. Control Hosp. Epidemiol., 27 (7), 645, 2006.
49. Best, M. and Neuhauser, D., Ignaz Semmelweis and the birth of infection control, Qual. Saf. Health Care, 13, 233, 2004.
50. Haley, R.W., Culver, D.H., White, J.W., Morgan, W.M., Emori, T.G., Munn, V.P., and Hootan, T.M., The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals, Am. J. Epidemiol., 121, 182, 1985.
51. Pittet, D., Mourouga, P., and Perneger, T.V., Compliance with handwashing in a teaching hospital. Infection control program, Ann. Intern. Med., 130 (2), 126, 1999.
52. Pittet, D., Hugonnet, S., Harbarth, S., Mourouga, P., Sauvan, V., Touveneau, S., and Perneger, T.V., Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection control programme, Lancet, 356 (9238), 1307, 2000.
53. Pittet, D., Improving adherence to hand hygiene practice: A multidisciplinary approach, Emerg. Infect. Dis., 7 (2), 234, 2001.
54. Boyce, J., It is time for action: Improving hand hygiene in hospitals, Ann. Intern. Med., 130, 153, 1999.
55. Boyce, J.M. and Pittet, D., Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force, Am. J. Infect. Control, 30 (8), S1, 2002.
56. Pyrek, K.M., Hand hygiene: New initiatives on the domestic and global fronts, Infection Control Today, 22 ff., 2006.
57. Pittet, D., Hugonnet, S., Harbarth, S., et al., Effectiveness of a hospital-wide programme to improve compliance with hand hygiene, Lancet, 356, 1307, 2000.
58. Kaiser, N.E. and Newman, J.L., Formulation technology as a key component in improving hand hygiene practices, Am. J. Infect. Control, 34 (10), S81, 2006.
59. Panhotra, B.R., Saxena, A.K., and Al-Mulhim, A.S., Contamination of patients’ files in intensive care units: An indication of strict handwashing after entering case notes, Am. J. Infect. Control, 33 (7), 398, 2005.
60. Sugarman, B. and Young, E.J., Infections associated with prosthetic devices: Magnitude of the problem, Infect. Dis. Clin. N. Am., 3, 187, 1989.
61. Donlan, R.M. and Costerton, J.W., Biofilms: Survival mechanisms of clinically relevant microorganisms, Clin. Microbiol. Rev., 15 (2), 167, 2002.
62. Donlan, R.M., New approaches for the characterization of prosthetic joint biofilms, Clin. Orthop. Relat. Res. (437), 12, 2005.
63. Borriello, G., Werner, E., Roe, F., Kim, A.M., Ehrlich, G.D., and Stewart, P.S., Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms, Antimicrob. Agents Chemother., 48, 2659, 2004.
64. Stoodley, P., Kathju, S., Hu, F.Z., Erdos, G., Levenson, J.E., Mehta, N., Dice, B., Johnson, S., et al., Molecular and imaging techniques for bacterial biofilms in joint arthroplasty infections, Clin. Orthoped. Relat. Res. (437), 31, 2005.
65. Patel, R., Biofilms and antimicrobial resistance, Clin. Orthoped. Relat. Res. (437), 41, 2005.
66. Allon, M., Saving infected catheters: Why and how, Blood Purif., 23 (1), 23, 2005.
67. Franco, F.F.S., Spratt, D., Leao, J.C., and Porter, S.R., Biofilm formation and control in dental unit waterlines, Biofilms, 2, 9, 2005.
68. Ehrlich, G.D., Stoodley, P., Kathju, S., Zhao, Y., McLeod, B., Balaban, N., Hu, F.Z., et al., Engineering approaches for the detection and control of orthopaedic biofilm infections, Clin. Orthoped. Relat. Res., 437, 59, 2005.
69. Maki, D.G. and Tambyah, P.A., Engineering out the risk of infection with urinary catheters, Emerg. Infect. Dis., 7, 1, 2001.
70. Stamm, W.E., Catheter associated urinary tract infections: Epidemiology, pathogenesis, and prevention, Am. J. Med., 91 (suppl 3B), 65S, 1991.
71. Burke, J.P. and Riley, D.K., Nosocomial urinary tract infection, Mayhall, C.G. (ed.), Hospital Epidemiology and Infection Control, Baltimore, Williams and Wilkins, 139, 1996.
72. Warren, J.W., Catheter-associated urinary tract infections, Infect. Dis. Clin. N. Am., 11, 609, 1997.
73. Kunin, C.M., Care of the urinary catheter, Urinary Tract Infections: Detection, Prevention and Management, Baltimore, Williams and Wilkins, Fifth edition, 227, 1997.
74. Wilson, M.E., Levins, R., and Spielman, A. (eds.), Disease in Evolution: Global Changes and Emergence of Infectious Diseases, New York Academy of Sciences, 740, 1, 1995.
75. Edler, A.A., Avian flu (H5N1): Its epidemiology, prevention, and implications for anesthesiology, J. Clin. Anesth., 18 (1), 1, 2006.
76. Salzberger, B. and Ruf, B., Avian influenza and pandemic influenza threat, Eur. J. Med. Res., 11 (1), 1, 2006.
77. Allen, P.J., Avian influenza pandemic: Not if, but when, Pediatr. Nurs., 32 (1), 76, 2006.
78. Lederberg, J., Infectious disease as an evolutionary paradigm, Emerg. Infect. Dis., 3 (4), 417, 1997.